share_log

HC Wainwright & Co. Upgrades Kazia Therapeutics to Buy, Announces $2 Price Target

HC Wainwright & Co. Upgrades Kazia Therapeutics to Buy, Announces $2 Price Target

HC Wainwright & Co.将Kazia Therapeutics上调为买入,宣布2美元的目标
Benzinga ·  2023/04/11 06:21

HC Wainwright & Co. analyst Sean Lee upgrades Kazia Therapeutics (NASDAQ:KZIA) from Neutral to Buy and announces $2 price target.

HC Wainwright & Co. 分析师肖恩·李将Kazia Therapeutics(纳斯达克股票代码:KZIA)从中性上调至买入,并宣布了2美元的目标股价

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发